Novation members selected St. Jude Medical for award based on improved patient outcomes with the ILUMIEN System
St. Jude Medical, Inc., a global medical device company, was recognized by Novation as the 2013 Innovative Technology Supplier of the Year. Novation members selected the St Jude Medical ILUMIEN PCI Optimization System based on their experience using the technology to deliver improved patient outcomes.
Novation works with its more than 100,000 members and affiliates to identify innovative technology that improves patient care or reduces the risk of harm to patients or providers, while simultaneously raising the standard of patient care and safety.
“Novation’s goals of improving patient outcomes through innovative technology align with our mission at St. Jude Medical to create cost-effective medical technologies that save and improve lives,” said Joel D. Becker, president of the St. Jude Medical Americas Division. “We are pleased that Novation has recognized the many patient and economic benefits of our ILUMIEN System, and look forward to continuing our partnership with Novation as we pursue new treatments, efficiencies and ideas that improve the lives of people affected by expensive epidemic diseases.”
The first-of-its-kind ILUMIEN System offers physicians advanced physiological and anatomical insight to improve the diagnosis and treatment of coronary artery disease. It helps physicians better understand which arteries should be treated and how best to treat them. The ILUMIEN System integrates both Fractional Flow Reserve (FFR) technology to measure blood flow blockage inside the coronary arteries and intravascular Optical Coherence Tomography (OCT) imaging technology to help physicians to visualize the area they are treating. Combined, the two technologies assist physicians in identifying culprit lesions responsible for a patient’s ischemia and provide physicians with precise measurements of lesion dimensions and vessel size and structure.
St. Jude Medical recently launched the next generation ILUMIEN System, the ILUMIEN OPTIS, which includes several first of its kind enhancements, including automated measurements and stent planning software tools. The OCT imaging technology now provides a real-time, three dimensional (3-D) reconstruction of the patient’s vessel, making it easier for physicians to visualize the area they are treating.
The FAME family of studies collectively add to the growing body of evidence demonstrating improved outcomes and cost-savings with the St. Jude Medical PressureWire. Further, there are currently more than 1,200 published articles with clinical evidence supporting St. Jude Medical’s FFR and OCT technologies.
For more information, visit St. Jude Medical.